Italy Biochips Market

ID: MRFR/HC/48215-HCR 200 Pages Satyendra Maurya Last Updated: September 17, 2026
Italy Biochips Market Research Report: Size, Share, Trend Analysis By Applications (Diagnostics, Drug Discovery, Gene Expression Analysis, Genetic Analysis), By Product Type (DNA Chips, Protein Chips, Cell-Based Chips), By Technology (Microarray Technology, Nanolithography, PCR-Based Technology, Mass Spectrometry) andBy End Use (Research Laboratories, Clinical Laboratories, Pharmaceutical Companies, Biotechnology Companies) - Growth Outlook & Industry Forecast 2025 To 2035
Italy Biochips Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)16.11%
2024 Market Size$ 350.34 Million
2025 Market Size$ 406.78 Million
2035 Market Size$ 1,811.91 Million
Key Players
Illumina
Thermo Fisher Scientific
Agilent Technologies
Bio-Rad Laboratories
Qiagen
Roche
Trends
  • Rising Demand for Personalized Medicine
  • Innovative Collaborations
  • Sustainability in Biotechnology
Opportunities
  • Growing Focus on Diagnostics
  • Government Initiatives and Funding
  • Technological Advancements in Biochips
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Application (USD Million)
      1. 4.1.1 Diagnostics
      2. 4.1.2 Drug Discovery
      3. 4.1.3 Gene Expression Analysis
      4. 4.1.4 Genetic Analysis
    2. 4.2 Construction, BY Product Type (USD Million)
      1. 4.2.1 DNA Chips
      2. 4.2.2 Protein Chips
      3. 4.2.3 Cell-Based Chips
    3. 4.3 Construction, BY Technology (USD Million)
      1. 4.3.1 Microarray Technology
      2. 4.3.2 Nanolithography
      3. 4.3.3 PCR-Based Technology
      4. 4.3.4 Mass Spectrometry
    4. 4.4 Construction, BY End-Use (USD Million)
      1. 4.4.1 Research Laboratories
      2. 4.4.2 Clinical Laboratories
      3. 4.4.3 Pharmaceutical Companies
      4. 4.4.4 Biotechnology Companies
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Illumina (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Thermo Fisher Scientific (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Agilent Technologies (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Bio-Rad Laboratories (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Qiagen (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Roche (CH)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 PerkinElmer (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Merck KGaA (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Fluidigm Corporation (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 ITALY MARKET ANALYSIS BY APPLICATION
    3. 6.3 ITALY MARKET ANALYSIS BY PRODUCT TYPE
    4. 6.4 ITALY MARKET ANALYSIS BY TECHNOLOGY
    5. 6.5 ITALY MARKET ANALYSIS BY END-USE
    6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CONSTRUCTION
    9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
    12. 6.12 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
    14. 6.14 CONSTRUCTION, BY PRODUCT TYPE, 2024 (% SHARE)
    15. 6.15 CONSTRUCTION, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 CONSTRUCTION, BY TECHNOLOGY, 2024 (% SHARE)
    17. 6.17 CONSTRUCTION, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    18. 6.18 CONSTRUCTION, BY END-USE, 2024 (% SHARE)
    19. 6.19 CONSTRUCTION, BY END-USE, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Million)
      4. 7.2.4 BY END-USE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Italy Construction Market Segmentation

Construction By Application (USD Million, 2025-2035)

  • Diagnostics
  • Drug Discovery
  • Gene Expression Analysis
  • Genetic Analysis

Construction By Product Type (USD Million, 2025-2035)

  • DNA Chips
  • Protein Chips
  • Cell-Based Chips

Construction By Technology (USD Million, 2025-2035)

  • Microarray Technology
  • Nanolithography
  • PCR-Based Technology
  • Mass Spectrometry

Construction By End-Use (USD Million, 2025-2035)

  • Research Laboratories
  • Clinical Laboratories
  • Italy Biochips Market Companies
  • Biotechnology Companies

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.